PVI
ABVX

Pine Valley Investments’s Abivax ABVX Stock Holding History

Pine Valley Investments’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Buy
+2,025
New +$229K 0.01% 517

Other funds holding ABVX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Pine Valley Investments's ABVX Position: Q2 2026 in Review

Pine Valley Investments opened a new position in Abivax (ABVX) in Q2 2026: 2,025 shares worth $270K. The stake represents 0.01% of the portfolio and ranks #517 among its holdings.

75 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Pine Valley Investments held 2,025 shares of Abivax worth $270K as of Q2 2026.
  • Abivax was a new Pine Valley Investments position in Q2 2026.
  • Abivax made up 0.01% of Pine Valley Investments's portfolio in Q2 2026, its #517 holding.
  • 75 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.